GSK terminates collaboration with Alector after trial failures
Go back to GSK terminates collaboration with Alector after trial failures| (NASDAQ: ALEC) | Delayed: 2.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.14 | 52 Week High | $ | |||
| Open | $2.17 | 52 Week Low | $ | |||
| Day High | $2.22 | P/E | N/A | |||
| Day Low | $2.02 | EPS | $ | |||
| Volume | 4,699,047 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.13 +0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.12 | 52 Week High | $45.58 | |||
| Open | $48.70 | 52 Week Low | $37.82 | |||
| Day High | $48.80 | P/E | N/A | |||
| Day Low | $47.85 | EPS | $0.00 | |||
| Volume | 2,281,895 | |||||
